Amedisys (AMED) Updates Earnings Guidance for FY2022

Trending News 🌥️

Amedisys Inc Intrinsic Stock Value – Amedisys Inc ($NASDAQ:AMED). is a leading home health care and hospice company that provides a wide range of services to patients and families across the United States. The company has updated its earnings guidance for FY 2022, and is expecting to see continued growth in its business. Amedisys has a strong track record of delivering quality care to its patients and families.

The company is focused on providing the best possible care to its patients, and is constantly innovating its services to meet the needs of its patients. Amedisys is committed to providing the highest quality of care to its patients, and its earnings guidance reflects this commitment.

Earnings

Amedisys Inc. is a healthcare services company that provides in-home health services and hospice care to patients in the United States. The company recently updated its earnings guidance for FY2022, reporting total revenue of $2220.5 million and net income of $120.9 million. Compared to the previous year, this represents a 0.3% increase in total revenue and a 42.2% decrease in net income. Over the last three years, Amedisys Inc.’s total revenue has grown from $2071.5 million to $2220.5 million. The company attributes the revenue growth to an increase in the number of patients served and an increase in the average length of stay for patients receiving hospice services.

However, the decrease in net income is due to a number of factors, including increased costs associated with serving a larger number of patients and increased investment in new technology and services.

Share Price

Amedisys Inc. announced on Wednesday that it was updating its earnings guidance for fiscal year 2022. The company attributed the revised guidance to “lower than expected volume in the first quarter” and said that it is taking “proactive measures” to address the issue. Despite the downward revision, Amedisys still expects to grow its earnings at a double-digit rate in fiscal year 2022.

The company also reaffirmed its guidance for revenue and Adjusted EBITDA for the year. Shares of Amedisys were down 5.7% in trading on Wednesday following the announcement.

VI Analysis – Amedisys Inc Intrinsic Stock Value

The company operates in three segments: Home Health, Hospice and Personal Care. The company’s fundamentals reflect its long term potential. The company’s earnings have been growing at a double-digit pace in recent years, and analysts expect this trend to continue. The company’s valuation is attractive at current levels.

In conclusion, Amedisys Inc. is a well-run company with strong fundamentals and attractive valuation. The stock is a good investment at current levels.

VI Peers

Its competitors include National Healthcare Corp, Aveanna Healthcare Holdings Inc, and Nova Leap Health Corp.

– National Healthcare Corp ($NYSEAM:NHC)

National Healthcare Corporation is a diversified healthcare services company that owns and operates long-term care facilities, hospitals, home health agencies, and hospice care businesses. The company has a market capitalization of $942.75 million and a return on equity of 2.65%. National Healthcare Corporation is headquartered in Nashville, Tennessee.

– Aveanna Healthcare Holdings Inc ($NASDAQ:AVAH)

Aveanna Healthcare Holdings Inc is a publicly traded company that provides health care services. The company has a market capitalization of 290.03 million as of 2022 and a return on equity of -71.08%. The company’s primary business is providing in-home health care services to patients. The company operates in the United States, Canada, and Puerto Rico.

– Nova Leap Health Corp ($TSXV:NLH)

Nova Leap Health Corp is a Canadian publicly traded company with a market cap of 23.25M as of 2022. The company is a provider of home health care services. The company has a Return on Equity of 1.6%. The company’s services include personal care, nursing, and homemaking services.

Summary

Amedisys Inc. is a leading provider of home healthcare services and solutions in the United States. The company offers a full range of services, including skilled nursing, physical therapy, occupational therapy, speech therapy, home health aides, and more. Amedisys Inc. has a strong track record of delivering quality care to its patients.

The company has been accredited by the Joint Commission, the nation’s leading accreditor of healthcare organizations. Investors seeking to add a healthcare provider with a proven track record of success to their portfolio may want to consider Amedisys Inc. .